| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/10/2009 | US20090227770 Polypeptide carrier protein |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227658 Methods and compositions for immunization against hiv |
| 09/10/2009 | US20090227517 Myostatin binding agents |
| 09/10/2009 | US20090227499 Soluble gp130 molecule variants useful as a medicament |
| 09/10/2009 | US20090227497 Variant activin receptor polypeptides and uses thereof |
| 09/10/2009 | US20090227496 Method of Producing Recombinant TAT-HOXB4H Protein for Use as a Stimulant of Hematopoiesis In Vivo |
| 09/10/2009 | US20090227021 Purified mammalian ctla-8 antigens and related reagents |
| 09/10/2009 | US20090227017 Nucleic acids encoding receptor for il-17 homologous polypeptides and uses thereof |
| 09/10/2009 | US20090227012 Nucleotide sequences coding modified immunoglobulin for use in prevention and treatment of cancer and/or inflammatory disease |
| 09/10/2009 | US20090227002 Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs |
| 09/10/2009 | US20090226970 Soluble fusion proteins comprising heterologous polypeptides |
| 09/10/2009 | US20090226969 Spider Silk Proteins and Methods for Producing Spider Silk Proteins |
| 09/10/2009 | US20090226968 Engineering Intracellular Sialylation Pathways |
| 09/10/2009 | US20090226967 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma |
| 09/10/2009 | US20090226966 Polypeptide having activity of aminoacyl-tRNA synthetase and use thereof |
| 09/10/2009 | US20090226965 Vaccine for preventing and treating porcine progressive atrophic rhinitis and making process thereof |
| 09/10/2009 | US20090226964 Polymyxin Synthetase and Gene Cluster Thereof |
| 09/10/2009 | US20090226963 Method for production of protein having non-natural type amino acid integrated therein |
| 09/10/2009 | US20090226962 Microbial strains and processes for the manufacture of biomaterials |
| 09/10/2009 | US20090226961 Mutant alpha-amylases |
| 09/10/2009 | US20090226960 Method for generating tethered proteins |
| 09/10/2009 | US20090226959 Production of modified glycoproteins having multiple antennary structures |
| 09/10/2009 | US20090226935 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 09/10/2009 | US20090226930 Beta cell antigen |
| 09/10/2009 | US20090226929 Titinic ion channel, compositions and methods of use |
| 09/10/2009 | US20090226919 Method for constructing an operon containing translationally coupled genes |
| 09/10/2009 | US20090226899 Methods of B-cell epitope antigenic systems-discovery |
| 09/10/2009 | US20090226571 Fermentative Production of Non-Volatile Microbial Metabolism Products in Solid Form |
| 09/10/2009 | US20090226564 Bacterial alpha-amylase variants |
| 09/10/2009 | US20090226505 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/10/2009 | US20090226487 Avian embryo particulate biomass for the production of virus antigens |
| 09/10/2009 | US20090226485 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 09/10/2009 | US20090226478 Early detection of flaviviruses using the NS1 glycoprotein |
| 09/10/2009 | US20090226472 Interleukin-4 receptors |
| 09/10/2009 | US20090226470 Compositions and methods related to mRNA translational enhancer elements |
| 09/10/2009 | US20090226469 Shiga Toxoid Chimeric Proteins |
| 09/10/2009 | US20090226466 Therapeutic anti-her2 antibody fusion polypeptides |
| 09/10/2009 | US20090226464 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
| 09/10/2009 | US20090226462 use of polypeptide in a vaccine for protection of fish from Aeromomas |
| 09/10/2009 | US20090226457 antibody that is immunoreactive with a polypeptide used in treating autoimmune and immunological diseases |
| 09/10/2009 | US20090226456 screening methods for identifying agonists and antagonists of TNFR-6 alpha & -6 beta activity; diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders; cancer |
| 09/10/2009 | US20090226451 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 09/10/2009 | US20090226450 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 09/10/2009 | US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226447 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 09/10/2009 | US20090226445 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/10/2009 | US20090226444 Pharmaceutical antibody compositions with resistance to soluble cea |
| 09/10/2009 | US20090226442 RON antibodies and uses thereof |
| 09/10/2009 | US20090226432 Pharmaceutical compositions with resistance to soluble cea |
| 09/10/2009 | US20090226430 Recombinant anti-cd4 antibodies for human therapy |
| 09/10/2009 | US20090226421 Recombinant monovalent antibodies and methods for production thereof |
| 09/10/2009 | US20090226417 Human B7 polypeptides |
| 09/10/2009 | US20090226415 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/10/2009 | US20090226413 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226410 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/09/2009 | EP2098591A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
| 09/09/2009 | EP2098246A1 Method for promoting immune response comprising inhibiting cd22 function in b cells |
| 09/09/2009 | EP2097529A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 09/09/2009 | EP1943338A4 Cell-free synthesis of membrane bound polypeptides |
| 09/09/2009 | EP1548028B1 Substituted type peptides of wt1 |
| 09/09/2009 | EP1453848A4 Sir2 products and activities |
| 09/09/2009 | EP1446733B1 Glycosylphosphatidylinositol containing polypeptides |
| 09/09/2009 | EP1279735B1 Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 09/09/2009 | EP0996857B1 Cancer associated nucleic acids and polypeptides |
| 09/09/2009 | EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/09/2009 | EP0817847B2 Il-17 receptor |
| 09/09/2009 | EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/09/2009 | CN101525629A Gene engineering preparation method of bioactive peptide containing human alpha defensin 5 |
| 09/09/2009 | CN101525628A Processes for preparing heterologous proteins in prokaryotic host cells |
| 09/09/2009 | CN101525614A Human oophoroma tumor marker HE4 enzymoimmunoassay kit |
| 09/09/2009 | CN101525387A Recombined long-acting glucagons peptide analogue and preparation method thereof |
| 09/09/2009 | CN101525384A A bispecific antibody and the making method and the application thereof |
| 09/09/2009 | CN101525376A Opioid peptide for source of Alphas1-casein and preparation method thereof |
| 09/09/2009 | CN101524370A Production technology of pig brain protolysate |
| 09/09/2009 | CN100537773C Modified vaccinia ankara virus variant |
| 09/08/2009 | US7585962 Gene therapy; expression of polynucleotide in nucleic acids in dopaminergic cell; Parkinson's disease |
| 09/08/2009 | US7585960 Encoding a binding molecule specifically binding to a human CD28 molecule; comprising a nucleic acid sequence encoding a VH region and a nucleic acid sequence encoding a VL region with CDRs in a human immunoglobulin framework |
| 09/08/2009 | US7585953 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 09/08/2009 | US7585952 Fully human miniantibody (scFv) called Erbicin, specific for the receptor ErbB2; antitumor; transmembrane tyrosine kinase receptor |
| 09/08/2009 | US7585949 immune response receptor protein and ligand for use in identifying modulators for treatment of inflammation, rheumatoid arthritis, myasthenia gravis, diabetes mellitus and muscular disorders |
| 09/08/2009 | US7585948 Soluble interleukin-20 receptor |
| 09/08/2009 | US7585947 IL-7 drug substance, composition, preparation and uses |
| 09/08/2009 | US7585946 Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions |
| 09/08/2009 | US7585936 Protein expression |
| 09/08/2009 | US7585849 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 09/08/2009 | US7585815 High throughput protein production screening |
| 09/08/2009 | US7585675 Antisense IL-4 inhibits viral replication in the liver, lungs, spleen, and even the lymph nodes; can be used in combination with other antiretroviral agents or vaccines |
| 09/08/2009 | US7585673 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 09/08/2009 | US7585671 Hedgehog interacting proteins and uses related thereto |
| 09/08/2009 | US7585658 Staphylococcus aureus antigenic polypeptides and compositions |
| 09/08/2009 | US7585657 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells; hemagglutinin (HA) and neuraminidase (NA). |
| 09/08/2009 | US7585655 Nucleic acid encoding a fusion protein incorporating a cysteinized ribonuclease |
| 09/08/2009 | US7585654 Nucleic acid encoding cysteinized ribonuclease to which a targeting moiety can be conjugated |
| 09/08/2009 | US7585647 with changed spatial configuration and improved efficacy; preventing or treating viral diseases; also an artificial gene which codes for the interferon |
| 09/08/2009 | US7585646 Human GIL-19/AE289 polynucleotides and methods of producing the encoded polypeptides |
| 09/08/2009 | US7585645 Obtaining oil bodies from a cell; washing oil bodies to obtain a washed oil body preparation; formulating washed oil bodies with thioredoxin or thioredoxin reductase into an emulsion |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | US7585619 Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity |